Clinical Trial

National Database on Primary Biliary Cholangitis

Study acronym: PBC322
Recruiting
View on ClinicalTrials.gov →
Summary
Primary biliary cholangitis (PBC) is a rare, autoimmune, cholestatic liver disease. No data about the disease epidemiology exist in Italy. Therefore this study aims to develop a national PBC patient database linked to a biological sample storage.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2021-11-25; most recent amendment 2025-07-24.
Trial Details
NCT Number NCT05151809
Lead Sponsor University of Milano Bicocca
Conditions Primary Biliary Cholangitis
Enrollment 6,000 participants
Start Date 2019-09-19
Primary Completion 2029-01-24 (estimated)
Study Completion 2029-01-24 (estimated)
Updated on ClinicalTrials.gov 2025-07-25